IL143802A0 - Imidazole derivatives and pharmaceutical compositions containing the same - Google Patents

Imidazole derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL143802A0
IL143802A0 IL14380299A IL14380299A IL143802A0 IL 143802 A0 IL143802 A0 IL 143802A0 IL 14380299 A IL14380299 A IL 14380299A IL 14380299 A IL14380299 A IL 14380299A IL 143802 A0 IL143802 A0 IL 143802A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
imidazole derivatives
imidazole
Prior art date
Application number
IL14380299A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL143802A0 publication Critical patent/IL143802A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14380299A 1998-12-24 1999-12-20 Imidazole derivatives and pharmaceutical compositions containing the same IL143802A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP36736298 1998-12-24
JP22883899 1999-08-12
PCT/JP1999/007160 WO2000039097A1 (fr) 1998-12-24 1999-12-20 Composes d'imidazole et utilisation medicinale de ces composes

Publications (1)

Publication Number Publication Date
IL143802A0 true IL143802A0 (en) 2002-04-21

Family

ID=26528483

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14380299A IL143802A0 (en) 1998-12-24 1999-12-20 Imidazole derivatives and pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (1) US7060721B1 (de)
EP (1) EP1142879B1 (de)
KR (1) KR20010094731A (de)
CN (1) CN1170822C (de)
AR (1) AR022019A1 (de)
AT (1) ATE375332T1 (de)
AU (1) AU758325C (de)
BR (1) BR9917112A (de)
CA (1) CA2356838A1 (de)
CZ (1) CZ20012338A3 (de)
DE (1) DE69937307T2 (de)
ES (1) ES2292262T3 (de)
HK (1) HK1043791A1 (de)
HU (1) HUP0104657A3 (de)
IL (1) IL143802A0 (de)
RU (1) RU2238937C2 (de)
TR (1) TR200101865T2 (de)
TW (1) TWI239330B (de)
WO (1) WO2000039097A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds
US20030181461A1 (en) * 2002-01-25 2003-09-25 Lautt Wilfred Wayne Use of phosphodiesterase antagonists to treat insulin resistance
AU2012200214B2 (en) * 2004-05-14 2013-10-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
MX2008001386A (es) * 2005-08-10 2008-04-07 Takeda Pharmaceutical Agente terapeutico para diabetes.
EP2013186A1 (de) * 2006-04-21 2009-01-14 AstraZeneca AB Imidazolderivate zur verwendung als edg-1-antagonisten
TW200838501A (en) * 2007-02-02 2008-10-01 Theravance Inc Dual-acting antihypertensive agents
BRPI0807014A2 (pt) * 2007-02-09 2014-04-22 Takeda Pharmaceutical Composto, pró-droga, agente farmacêutico, métodos para melhorar a resistência a insulina em um mamífero, método para a profilaxia ou o tratamento de diabetes em um mamífero, e, uso de um composto.
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
TWI406850B (zh) * 2007-06-05 2013-09-01 Theravance Inc 雙效苯并咪唑抗高血壓劑
KR100868898B1 (ko) * 2007-07-30 2008-11-14 한국기계연구원 적층형 pzt를 이용한 압전펌프
WO2009035543A1 (en) 2007-09-07 2009-03-19 Theravance, Inc. Dual-acting antihypertensive agents
CA2705921A1 (en) 2007-12-11 2009-06-18 Theravance, Inc. Dual-acting benzoimidazole derivatives and their use as antihypertensive agents
US7989484B2 (en) 2008-04-29 2011-08-02 Theravance, Inc. Dual-acting antihypertensive agents
US8124636B2 (en) * 2008-04-30 2012-02-28 Hoffmann-La Roche Inc. Imidazolidinone derivatives as 11B-HSD1 inhibitors
US7863309B2 (en) 2008-07-24 2011-01-04 Theravance, Inc. Dual-acting antihypertensive agents
EP2430002B1 (de) * 2009-05-15 2013-07-24 Sanofi Verfahren zur herstellung einer verbindung, die als ein inhibitor von tafia von nutzen ist
JP5833000B2 (ja) 2009-07-07 2015-12-16 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー 二重に作用するピラゾール抗高血圧症薬
WO2011011232A1 (en) 2009-07-22 2011-01-27 Theravance, Inc. Dual-acting oxazole antihypertensive agents
US8481549B2 (en) 2010-01-19 2013-07-09 Theravance, Inc. Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
AR116113A1 (es) * 2018-09-04 2021-03-31 Chugai Pharmaceutical Co Ltd Método para fabricar un compuesto tetracíclico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
TW235963B (de) 1992-01-16 1994-12-11 Shionogi & Co
BR9612434A (pt) 1995-12-28 1999-12-28 Fujiwasa Pharmaceutical Co Ltd Derivados de benzimidazol
BR9810456A (pt) 1997-06-27 2001-09-25 Fujisawa Pharmaceutical Co Composto de sulfonamida, método para sua obtenção e seu uso farmacêutico
EP1000932B9 (de) 1997-06-27 2005-12-28 Fujisawa Pharmaceutical Co., Ltd. Derivate mit einem aromatischen ring

Also Published As

Publication number Publication date
US7060721B1 (en) 2006-06-13
TWI239330B (en) 2005-09-11
HK1043791A1 (en) 2002-09-27
AR022019A1 (es) 2002-09-04
CA2356838A1 (en) 2000-07-06
AU1690500A (en) 2000-07-31
KR20010094731A (ko) 2001-11-01
RU2238937C2 (ru) 2004-10-27
EP1142879B1 (de) 2007-10-10
DE69937307T2 (de) 2008-02-07
TR200101865T2 (tr) 2001-12-21
CN1335837A (zh) 2002-02-13
BR9917112A (pt) 2002-01-29
HUP0104657A2 (hu) 2002-05-29
DE69937307D1 (de) 2007-11-22
AU758325B2 (en) 2003-03-20
CZ20012338A3 (cs) 2001-12-12
AU758325C (en) 2004-10-07
ES2292262T3 (es) 2008-03-01
EP1142879A1 (de) 2001-10-10
HUP0104657A3 (en) 2002-07-29
CN1170822C (zh) 2004-10-13
EP1142879A4 (de) 2002-02-06
WO2000039097A1 (fr) 2000-07-06
ATE375332T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL113196A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
IL143799A0 (en) Phenoxyphenyl derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL139479A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL141456A0 (en) Rhodanine derivatives and pharmaceutical compositions containing the same
HUP0202648A3 (en) Imidazolyl derivatives, pharmaceutical compositions containing them and their use
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL142665A0 (en) Acyl dipeptidyl derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL138573A0 (en) Amide derivatives and pharmaceutical compositions containing the same
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL138572A0 (en) Benzoate derivatives and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same